HCPCS Codes Similar to G9959

HCPCS Codes Similar to “G9959” Code.
Systemic antimicrobials not prescribed

G9960 Documentation of medical reason(s) for prescribing systemic antimicrobials Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON	G9961 Systemic antimicrobials prescribed Code added date: 20180101 Code effective date: 20180101 TXT \| PDF \| XML \| JSON
E0767 Intrabuccal, systemic delivery of amplitude-modulated, radiofrequency electromagnetic field device, for cancer treatment, includes all accessories Code added date: 20241001 Code effective date: 20241001 TXT \| PDF \| XML \| JSON	G8749 Absence of signs of melanoma (tenderness, jaundice, localized neurologic signs such as weakness, or any other sign suggesting systemic spread) or absence of symptoms of melanoma (cough, dyspnea, pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma) Code added date: 20120101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
G8750 Presence of signs of melanoma (cough, dyspnea, tenderness, localized neurologic signs such as weakness, jaundice or any other sign suggesting systemic spread) or presence of symptoms of melanoma (pain, paresthesia, or any other symptom suggesting the possibility of systemic spread of melanoma) Code added date: 20120101 Code effective date: 20130101 TXT \| PDF \| XML \| JSON	G8880 Documentation of reason(s) sentinel lymph node biopsy not performed (e.g., reasons could include but not limited to; non-invasive cancer, incidental discovery of breast cancer on prophylactic mastectomy, incidental discovery of breast cancer on reduction mammoplasty, pre-operative biopsy proven lymph node (ln) metastases, inflammatory carcinoma, stage 3 locally advanced cancer, recurrent invasive breast cancer, clinically node positive after neoadjuvant systemic therapy, patient refusal after informed consent, patient with significant age, comorbidities, or limited life expectancy and favorable tumor; adjuvant systemic therapy unlikely to change) Code added date: 20120101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
G9128 Oncology; disease status; limited to multiple myeloma, systemic disease; smoldering, stage i (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9129 Oncology; disease status; limited to multiple myeloma, systemic disease; stage ii or higher (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON
G9130 Oncology; disease status; limited to multiple myeloma, systemic disease; extent of disease unknown, staging in progress, or not listed (for use in a medicare-approved demonstration project) Code added date: 20060101 Code effective date: 20070101 TXT \| PDF \| XML \| JSON	G9652 Patient has been treated with a systemic or biologic medication for psoriasis for at least six months Code added date: 20160101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON
G9653 Patient has not been treated with a systemic or biologic medication for psoriasis for at least six months Code added date: 20160101 Code effective date: 20170101 TXT \| PDF \| XML \| JSON	G9764 Patient has been treated with a systemic medication for psoriasis vulgaris Code added date: 20170101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON
G9765 Documentation that the patient declined change in medication or alternative therapies were unavailable, has documented contraindications, or has not been treated with a systemic medication for at least six consecutive months (e.g., experienced adverse effects or lack of efficacy with all other therapy options) in order to achieve better disease control as measured by pga, bsa, pasi, or dlqi Code added date: 20170101 Code effective date: 20190101 TXT \| PDF \| XML \| JSON	G9847 Patient received systemic cancer-directed therapy in the last 14 days of life Code added date: 20170101 Code effective date: 20230101 TXT \| PDF \| XML \| JSON